Skip to Main Content
Information for
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
MENU
MENU
About YSM
History, Facts & Figures
Leadership, Administration & Governance
YSM Dean & Deputy Deans
YSM Administration
Department Chairs
Committees & Workgroups
YSM Executive Group
YSM Board of Permanent Officers
Current Searches
Chair Searches
Leadership Searches
Faculty Advisory Council
FAC Documents
Appointments & Promotions Committees
Info For Committee Members (login)
Ad Hoc Committees and Working Groups
Organization Charts
State of the School
Faculty Demographic Data
Professionalism Reporting Data
2022 Diversity Engagement Survey
State of the School Archive
Strategic Planning
Office of the Dean
Beyond Sterling Hall
Dean's Workshop
COVID-19 Series Workshops
Previous Workshops
Mission Statement & Process
Departments & Sections
Find People
Giving to YSM
Cancer
Biomedical Data Science
Health Equity
Inflammation
Neuroscience
Education
Global Health
Diabetes and Metabolism
Policies & Procedures
Contact Us
Media Relations
A-Z Websites & Lists
A-to-Z Websites
A to Z YSM Lab Websites
A-Z Faculty List
A-Z Staff List
A to Z Abbreviations
Diversity
Who We Are
Dept. Diversity Vice Chairs & Champions
For Faculty & Staff
Dean’s Advisory Council on Lesbian, Gay, Bisexual, Transgender, Queer and Intersex Affairs Website
Minority Organization for Retention and Expansion Website
Office for Women in Medicine and Science
Committee on the Status of Women in Medicine Website
Director of Scientist Diversity and Inclusion
Diversity Supplements
For Students, Trainees, & Postdocs
YSM Science Fellows Program
Frequently Asked Questions
Yale Black Postdoc Association
About Us
People
What We Do
News
Strategic Initiatives
Recruitment
Retention
Inclusion
By Department & Program
News & Events
Program for Art in Public Spaces
Executive Committee
AIDS
Aperture: Women in Medicine
Self-Reflection
Portraits of Strength
Event Photo Galleries
Additional Support
Anti-Racism Resources
Education
MD Program
MD-PhD Program
PA Program
PA Online Program
Joint MD Programs
MHS Program
How to Apply
Advanced Health Sciences Research
Clinical Informatics & Data Science
Clinical Investigation
Medical Education
MHS Team
Visiting Student Programs
Special Programs & Student Opportunities
Residency & Fellowship Programs
Center for Med Ed
Office of the Deputy Dean
Organizational Chart
Faculty
Academic/Professional Development
Physician/Scientist Development
Janeway Society
Membership
First Fridays
Yale Physician-Scientist Development Awards
Awardees
Yale International Physician-Scientist Resident and Fellow Research Award
Fund for Physician-Scientist Mentorship
Resources
Grant Library
Grant Writing Course
Mock Study Section
Research Paper Writing
Funding Opportunities
News
Engaging with Students
Join Our Voluntary Faculty
Faculty Directory
A-Z Faculty List
Research
Research by Keyword
Research by Department
Research by Global Location
Translational Research
Research Cores & Services
Resources for Investigators
Team Science
Program for the Promotion of Interdisciplinary Team Science (POINTS)
Studios
Health Equity Research
About Us
Community-Engaged Research (CEnR)
CEnR Steering Committee
Experiential Learning Subcommittee
Resources
OHER News
YSM Biobank
Goals & Objectives
Inventory
Pricing
Contact Us
Embryonic Stem Cell Research Oversight
Strategic Planning
COVID-19 Research
Mapping COVID-19 Data
COVID-19 Vaccinations in CT
Case Maps
COVID-19 in Connecticut Schools
Connecticut Towns COVID-19 Impact Dashboard
Connecticut Town 14-Day Cases Time Lapse
CT Correctional Facilities with COVID Cases Dashboard
Connecticut COVID Presence Map
CT Nursing Homes with COVID-19 Cases
U.S. COVID Presence Map
COVID-19 Case Density by US County
Global Cases Dashboard
Time-Lapse of Global Spread
US Racial and Ethnic Disparities in COVID-19 Mortality
Childcare Survey and Data Display
Risk of Complications Conditional on COVID-19 Infection
Geographic Access
Travel Time to COVID Testing Sites in Connecticut
Travel Time to COVID Testing Sites in the US
Project Team
News
Beyond Sterling Hall
Yale Medicine Magazine
Issues List
Print Magazine PDFs
Medicine@Yale
Issues List
Print Newsletter PDFs
YSM Events Newsletter
Social Media
Patient Care
YSM Home
INFORMATION FOR
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Download
Hi-Res Photo
Katherine Harvey, MD, MPH
Assistant Professor of Medicine (Medical Oncology)
Contact Information
Katherine Harvey, MD, MPH
Office
203.785.5196
Email
katherine.harvey@yale.edu
Related Links
Dr. Harvey at Torringinton Care Center
Yale Medicine
Patient Care
Are you a patient?
Please visit the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor Profile
Research & Publications
Biography
News
Clinical Trials
Conditions
Study Title
Lung
Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Breast
An Open-Label Phase II Trial to Evaluate the Efficacy and Safety of Neoadjuvant Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel Plus Trastuzumab and Pertuzumab in Early Stage HER2-Negative Breast Cancer Patients Selected With a Test Measuring Live Cell HER2 Signaling Transduction (FACT 1)
Prostate
Randomized Three-Arm Trial to Evaluate the Effect of Neoadjuvant Apalutamide Alone or in Combination With Abiraterone Acetate and GnRH Agonist on Enhancing Surgical Outcome of Nerve-Sparing Radical Prostatectomy in Men With High-Risk Prostate Cancer
Other Endocrine System; Pancreas
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
Non-Hodgkin's Lymphoma
A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
Multiple Myeloma
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
Pancreas
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Prostate
SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer
Multiple Myeloma
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Breast
A Randomized Phase II Trial Of Circulating Tumor DNA-Guided Second Line Adjuvant Therapy For High Residual Risk, Stage II-III, Hormone Receptor Positive, HER2 Negative Breast Cancer
Lung
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Corpus Uteri
A Phase II Evaluation of the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Persistent or Recurrent Endometrial Cancer
Other Female Genital; Ovary
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Corpus Uteri
A Phase II Evaluation of Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-drug Conjugate, in Patients With Persistent or Recurrent Endometrial Carcinoma
Multiple Myeloma
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Prostate
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Pancreas
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma
Lung
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
Lung
A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination With Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) With Immunobiomarker SIGNature-Driven Analysis
Leukemia, not otherwise specified; Leukemia, other
Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
Edit Profile
Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads
[0,1,2,5,112,95]
{"namedChunks":["modules-page-components-ComponentWrapper","modules-profile-components-profile-details-ProfileDetails","modules-footer-components-Footer"]}
[0,1,2,5,114,98]
{"namedChunks":["modules-page-components-ComponentWrapper","modules-profile-components-profile-details-ProfileDetails","modules-footer-components-Footer"]}